INBRAIN partners with Microsoft to apply agentic AI to graphene BCI platform for precision neurology
Summary
INBRAIN Neuroelectronics announced a partnership with Microsoft in November 2025 to explore advancing precision neurology by applying agentic AI to their graphene BCI platform. The collaboration will develop AI agents that can interpret INBRAIN's high-resolution graphene electrode data — which captures neural signals at resolution that conventional metal electrodes cannot achieve — to identify surgical margins, detect pathological tissue, and guide therapeutic neurostimulation in real time. Microsoft's Azure AI infrastructure will process INBRAIN's intraoperative neural data streams.
Why it matters
Microsoft partnering with a neural interface company on agentic AI is the first major tech company investment specifically in graphene BCI data interpretation. The combination of INBRAIN's unprecedented neural recording resolution and Microsoft's frontier AI capabilities could produce a surgical AI that identifies tumor boundaries and guides resection with precision no human surgeon can achieve unaided.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial